|
|
|
|
|
| Should You Choose An FSP Model? It Depends… | From The Editor | By Dan Schell, chief editor, Clinical Leader | Small biotechs are often drawn to an FSP model because they believe it’s a less expensive option as compared to an FSO. But that’s not always the case, says Réne Stephens of Danforth Advisors, who gives some examples of what to consider before making your choice of outsourcing solution. |
|
|
| Essential Laboratory Services For Vaccine Trials | Article | Cerba Research | Testing vaccines is a rigorous but essential multi-stage process. From initial lab research to human trials and regulatory approval, discover how vaccines undergo scrutiny to protect public health. |
|
|
| Working With An In-Country Clinical Trial Depot | Article | By Soudeh F. Tehrani, Lisa Lemelin, and Anh-Thu Le, Ropack Pharma Solutions | If you’re launching an international clinical trial, consider the noteworthy benefits of partnering with an in-country depot, including increased efficiency, reduced costs, and reliable access to raw materials. |
|
|
|
|
| Bioanalysis Solutions | Brochure | SGS | Learn how a bioanalytical testing partner with comprehensive solutions and unwavering commitment to quality can help you bring safe and effective drugs to market with confidence. |
|
|
|
|
| A Full-Service Solution Partner Disrupting the Outsourcing Paradigm | inSeption Group offers a full-service solution designed to disrupt the current outsourcing paradigm, resurrecting a common-sense approach to rebuild business trust and confidence in a client’s selected vendor. Primarily focused on oncology, hematology, neurodegenerative disorders, and rare/orphan disease indications, with a specialization in cell and gene therapy, inSeption has been a solution for its’ clients who have experienced the progressive degradation of today’s outsourcing options. Contact them. |
|
|
|
|
| 2025 Safety And Regulatory Compliance Trends And Predictions | White Paper | By Patrick Brady, PharmD, Sabika Rizvi, Ph.D., Marcela Miño, Ana Pedro Jesuíno, and Simon Johns, IQVIA Safety & Regulatory Compliance | Explore the rapidly evolving regulatory landscape that pharmaceutical and biotech industries face as they integrate AI and advanced technologies into safety, compliance, and lifecycle management. |
|
|
|
| Connect With Clinical Leader: |
|
|
|
